Metropolitan Life Insurance Company (MetLife)’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,727
| Closed | -$27.8K | – | 105 |
|
|
2024
Q1 | $27.8K | Hold |
2,727
| – | – | ﹤0.01% | 1695 |
|
|
2023
Q4 | $30.7K | Hold |
2,727
| – | – | ﹤0.01% | 1709 |
|
|
2023
Q3 | $7.09K | Hold |
2,727
| – | – | ﹤0.01% | 2352 |
|
|
2023
Q2 | $9.63K | Buy |
+2,727
| New | +$9.63K | ﹤0.01% | 2316 |
|
|
2022
Q2 | – | Sell |
-2,806
| Closed | -$17.1K | – | 2370 |
|
|
2022
Q1 | $17.1K | Sell |
2,806
-8,245
| -75% | -$50.2K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $101K | Buy |
11,051
+898
| +9% | +$8.23K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $115K | Buy |
10,153
+354
| +4% | +$4K | ﹤0.01% | 2447 |
|
|
2021
Q2 | $96.5K | Buy |
+9,799
| New | +$96.5K | ﹤0.01% | 2604 |
|